Publicaciones en las que colabora con Javier Pascau González-Garzón (13)

2020

  1. Association of visual and quantitative heterogeneity of 18F-FDG PET images with treatment response in locally advanced rectal cancer: A feasibility study

    PloS one, Vol. 15, Núm. 11, pp. e0242597

2008

  1. Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Núm. 1, pp. 257-266

2007

  1. Changes in cortical volume with olanzapine in chronic schizophrenia

    Pharmacopsychiatry, Vol. 40, Núm. 4, pp. 135-139

2005

  1. Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement

    Psychopharmacology, Vol. 178, Núm. 1, pp. 17-26

  2. Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia

    Schizophrenia Research, Vol. 80, Núm. 1, pp. 61-71

  3. N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration

    Schizophrenia Research, Vol. 73, Núm. 2-3, pp. 209-219

  4. Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia

    International Clinical Psychopharmacology, Vol. 20, Núm. 1, pp. 13-18

2003

  1. Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 124, Núm. 3, pp. 153-161

  2. Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 124, Núm. 3, pp. 163-175

  3. Cerebral metabolic patterns in chronic and recent-onset schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 122, Núm. 2, pp. 125-135

  4. Cerebral metabolism and risperidone treatment in schizophrenia

    Schizophrenia Research, Vol. 60, Núm. 1, pp. 1-7

2002

  1. Association between relative temporal and prefrontal sulcal cerebrospinal fluid and illness duration in schizophrenia

    Schizophrenia Research, Vol. 58, Núm. 2-3, pp. 305-312

  2. Multimodal neuroimaging studies and neurodevelopment and neurodegeneration hypotheses of schizophrenia

    Neurotoxicity Research, Vol. 4, Núm. 5-6, pp. 437-451